111 Inc
NASDAQ:YI
111 Inc
Net Income (Common)
111 Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Net Income (Common)
-¥392.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Net Income (Common)
¥891.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Net Income (Common)
¥363.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Net Income (Common)
¥1.4B
|
CAGR 3-Years
27%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Net Income (Common)
¥1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Net Income (Common)?
Net Income (Common)
-392.7m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Net Income (Common) amounts to -392.7m CNY.
What is 111 Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-1%
Over the last year, the Net Income (Common) growth was 6%. The average annual Net Income (Common) growth rates for 111 Inc have been 5% over the past three years , -1% over the past five years .